Pfizer & AstraZeneca vaccines effective against Indian Variant of COVID-19

Research conducted by experts from the Public Health Service in England shows that the American Pfizer (BioNTech vaccine in Germany) and the British AstraZeneca are quite effective against the Indian variant of COVID-19.

The research results published by the service show that the effectiveness of Pfizer against the Indian strain of coronavirus two weeks after the introduction of two doses reaches 88%, AstraZeneca – 60%.

“I’m more and more convinced that we are on track to implement the roadmap, because this data shows that the vaccine after two doses works effectively (against the Indian version) ”, – said in this regard, UK Health Minister Matt Hancock.

The data is groundbreaking, he said, and he hopes the government will be able to lift more coronavirus-related restrictions next month, in line with its roadmap. According to government plans, the lifting of the remaining restrictions on coronavirus should begin on June 21.
The Indian vaccine Covaxin made by Bharat Biotech is also found to be affective against the Indian variant, but is not in the WHO’s Emergency Use Listing (EUL), a prerequisite for COVAX Facility vaccine supply. The vaccine also suffered an image problem because of Modi Governmnt’s questionable approval for emergency use when the vaccine was in the third stage of trial.

At the end of March, a new variant of the double mutation coronavirus, also known as B.1.617, was discovered in India. This variant is more contagious than the “regular” SARS-CoV-2 coronavirus, first identified in China’s Wuhan province in early 2020. Prior to this, it became known about the “British” and “Brazilian” variants of the coronavirus, which also differed in increased infectivity compared to the “Wuhan” coronavirus. The Indian government has said that  B.1.617 has not been called the Indian variant by the WHO.

Latest

Spain buys 20 Eurofighter Typhoon Tranche 4 under Halcón project with E-Scan AESA

The Halcón project (Falcon in English) is now a...

Russia captures French Caesar self-propelled guns

Russian troops have already captured two Caesar self-propelled guns...

Why did India choose Rafale when SU-30 MKI is faster and more agile?

The Sukhoi Su-30MKI has long served as the backbone...

Rozlyn Khan is a stinging red dress

Actress Rozlyn Khan appears in a stinging red dress...

Newsletter

spot_img

From Same Category

Japan is developing a vaccine that gives permanent immunity to COVID-19

In Japan, a vaccine against COVID-19 is in development,...

Pfizer anti-Covid pill Paxlovid: how and when to use it

The U.S. has given the green light for Pfizer's...

Novavax protein vaccine: how it works, side effects of the COVID-19 jab

A protein vaccine differs from the mRNA vaccines (Pfizer...

Another foreign made COVID vaccine, ‘Covovax’, gained WHO approval

WHO has made a written statement regarding the use...

All you want to know about the South African coronavirus variant is called Omicron

WHO has designated the new variant of SARS-CoV-2 detected...
Frontier India News Network
Frontier India News Network
Frontier India News Network is the in-house news collection and distribution agency.
spot_imgspot_img

Spain buys 20 Eurofighter Typhoon Tranche 4 under Halcón project with E-Scan AESA

The Halcón project (Falcon in English) is now a reality. NATO Eurofighter 2000 and Tornado Management Agency (NETMA) signed a contract during the ILA...

Russia captures French Caesar self-propelled guns

Russian troops have already captured two Caesar self-propelled guns recently delivered from France in Ukraine, said the French lawyer and politician Régis de Castelnau. The...

Why did India choose Rafale when SU-30 MKI is faster and more agile?

The Sukhoi Su-30MKI has long served as the backbone of the Indian Air Force (IAF). This multi-role combat aircraft was jointly developed for the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here